|
Research Management and Support
|
RMS ES 2018
|
$340,640,887
|
$108,000
|
N/A
|
National Institutes of Health
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S1
|
|
$0
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S2
|
$64,741
|
$64,741
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S3
|
$229,232
|
$229,232
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S4
|
$593,811
|
$593,811
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S5
|
$917,771
|
$917,771
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S6
|
$68,356
|
$68,356
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S7
|
$778,576
|
$778,576
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S8
|
$73,651
|
$73,651
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Solid Malignancy Integrated Translational Science Center
|
5U10CA180884-02
|
$400,000
|
$400,000
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
5U10CA180886-02
|
$24,080,302
|
$24,080,302
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
CCNY-MSKCC Partnership for Cancer Research Training & Community Outreach (1 of 2
|
3U54CA137788-10S1
|
$54,859
|
|
AHLES, TIM
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
CCNY-MSKCC Partnership for Cancer Research Training & Community Outreach (1 of 2
|
3U54CA137788-10S2
|
$188,884
|
|
AHLES, TIM
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Mechanisms of T cell leukemia induction and maintenance
|
5R01CA149655-05
|
$340,155
|
$340,155
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Prospective study of farmers and their families (Agricultural health study)
|
ZIA CP010119 - 02020
|
$430,051
|
$43,005
|
Alavanja, Michael
|
DCEG (NCI)
|
|
Redefining Langerhans Cell Histiocytosis as a Myeloid Dysplasia and Identifying B
|
5R01CA154489-05
|
$326,398
|
$326,398
|
ALLEN, CARL
|
BAYLOR COLLEGE OF MEDICINE
|
|
Oncohistones: Role of Histone H3 Mutations in the Oncogenesis of Pediatric Cancer
|
1P01CA196539-01
|
$2,023,721
|
$2,023,721
|
ALLIS, CHARLES
|
ROCKEFELLER UNIVERSITY
|
|
Inherited bone marrow failure syndromes study
|
ZIA CP010144 - 07130
|
$1,717,771
|
$1,717,771
|
Alter, Blanche
|
DCEG (NCI)
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-46S1
|
$138,748
|
$2,775
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-49S1
|
$142,498
|
$2,850
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-49S2
|
$200,000
|
$4,000
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-46
|
$2,578,347
|
$51,567
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-49
|
$2,645,581
|
$52,912
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
A novel functional genomic pipeline for target identification in sarcoma
|
5R21CA187516-02
|
$165,530
|
$165,530
|
AMATRUDA, JAMES
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Role of IGF-IR tyrosine kinase in NPM-ALK-expressing T-cell lymphoma
|
5R01CA151533-05
|
$327,850
|
$81,963
|
AMIN, HESHAM
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
The role of ATRX and H3.3 mutations in pediatric glioblastoma
|
5F32CA189741-02
|
$54,194
|
$54,194
|
ANASTAS, JAMIE
|
CHILDREN'S HOSPITAL CORPORATION
|
|
General Descriptive Studies
|
ZIA CP010183 - 00350
|
$121,254
|
$12,125
|
Anderson, William
|
DCEG (NCI)
|
|
Collaborative Pathways that Lead to Leukemia
|
ZIA BC 010982
|
$261,157
|
$261,157
|
Aplan, Peter
|
CCR (NCI)
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
ZIA SC 010378
|
$522,314
|
$261,157
|
Aplan, Peter
|
CCR (NCI)
|
|
Mechanisms of Chromosomal Translocation
|
ZIA SC 010379
|
$261,157
|
$104,463
|
Aplan, Peter
|
CCR (NCI)
|
|
Toxicity Monitoring on Phase III Trials with Administrative Data
|
5R01CA165277-04
|
$410,314
|
$410,314
|
APLENC, RICHARD
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Reducing risk of Anthracycline-related heart failure after childhood cancer
|
1R01CA196854-01
|
$725,110
|
$725,110
|
ARMENIAN, SARO
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Childhood Cancer Survivor Study
|
3U24CA055727-24S1
|
$120,439
|
$120,439
|
ARMSTRONG, GREGORY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Longitudinal Cardiotoxicity in Adult Survivors Childhood Cancer
|
5R01CA157838-04
|
$600,509
|
$600,509
|
ARMSTRONG, GREGORY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Targeting to Epigenetic Modications in ALL
|
5R01CA176745-05
|
$402,250
|
$402,250
|
ARMSTRONG, SCOTT
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Childhood Cancer Survivor Study
|
5U24CA055727-21
|
$4,271,782
|
$3,844,604
|
ARMSTRONG, GREGORY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Stanford Cancer Institute
|
3P30CA124435-11S1
|
$248,520
|
$2,485
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
Stanford Cancer Institute
|
3P30CA124435-11S2
|
$171,518
|
$1,715
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
Stanford Cancer Institute
|
5P30CA124435-11
|
$3,334,464
|
$33,345
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
3P30CA142543-09S1
|
$249,371
|
$19,950
|
ARTEAGA, CARLOS
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
5P30CA142543-09
|
$2,480,000
|
$198,400
|
ARTEAGA, CARLOS
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Significance of Marrow Karyotypes in Inherited Bone Marrow Failure Syndromes
|
ZIA BC 010692
|
$38,443
|
$7,689
|
Arthur, Diane
|
CCR (NCI)
|
|
Clinical Cancer Cytogenetics
|
ZID BC 010694
|
$653,524
|
$130,705
|
Arthur, Diane
|
CCR (NCI)
|
|
Molecular Diagnostics for Risk Stratification and Monitoring of Neuroblastoma
|
5R01CA182633-02
|
$671,686
|
$671,686
|
ASGHARZADEH, SHAHAB
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Cancer Center Support Grant
|
2P30CA082103-19
|
$7,954,381
|
$636,350
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-17S2
|
$50,000
|
$6,000
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-17S3
|
$124,967
|
$14,996
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-17S4
|
$199,969
|
$23,996
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-17S5
|
$158,600
|
$19,032
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-19S1
|
$84,000
|
$6,720
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
Total relevant funding to Childhood Cancers for this search: $228,410,119
|